A new review reveals how lactate and its derivative lactylation process drive breast cancer progression, opening new therapeutic possibilities. The study demonstrates that lactate—a metabolic ...
Front-line use of FOLFOXIRI plus bevacizumab and subsequent therapies in metastatic colorectal cancer (mCRC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results